 |
Central Nervous System Stimulants (Latest Articles)
Latest indexed articles for 'Central Nervous System Stimulants'
Articles 81 to 90 of 200:
Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
29 Jun 2009 
This study was performed to evaluate the actions of baclofen and sodium oxybate, two medications with gamma-aminobutyric acid type B (GABA(B)) receptor agonist properties, on symptoms of narcolepsy in drug-naïve teenagers. Twenty-six narcoleptic ...
rec_pub_19520267-narcolepsy-action-two-gamma-aminobutyric-acid-type-b-agonists.htm
Nonmedical use of prescription opioids and stimulants among student pharmacists.
29 Jun 2009 OBJECTIVES: To examine the prevalence and patterns of nonmedical use of prescription opioid analgesics and stimulants among student pharmacists. DESIGN: Descriptive, nonexperimental, cross-sectional study. SETTING: Private urban college of pharmacy ...
rec_pub_19589764-nonmedical-use-prescription-opioids-stimulants-student-pharmacists.htm
"Hey, doc, is it OK for me to drink coffee?".
29 Jun 2009 
rec_pub_19559157-hey-doc-ok-drink-coffee.htm
Cardiovascular effects of methylphenidate.
29 Jun 2009
rec_pub_19559283-cardiovascular-effects-methylphenidate.htm
Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth?
28 Jun 2009 OBJECTIVE: To evaluate the impact of psychopharmacologic treatments on neuropsychological functioning in bipolar youth. METHOD: Participants were 173 children (aged 6-17 years) with DSM-IV bipolar disorder. Participants were comprehensively assessed ...
rec_pub_19573494-is-psychopharmacologic-treatment-associated-neuropsychological.htm
Modafinil for the treatment of cocaine dependence.
24 Jun 2009 AIM: Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo. METHODS: This was a double-blind placebo-controlled study, with 12 weeks of treatment and a 4-week follow-up. Six outpatient ...
rec_pub_19560290-modafinil-treatment-cocaine-dependence.htm
Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.
22 Jun 2009 Methamphetamine (METH) is a psychostimulant that causes damage to dopamine (DA) axons and to non-monoaminergic neurons in the brain. The aim of the present study was to investigate short- and long-term effects of neurotoxic METH treatment on ...
rec_pub_19559060-methamphetamine-treatment-causes-delayed-decrease-novelty-induced.htm
20 Jun 2009 Methylphenidate is a central nervous system (CNS)-stimulating agent. During recent years methylphenidate has been shown to increase arousal in patients with traumatic brain injury. We describe a patient with a severe traumatic injury in whom arousal ...
rec_pub_19671403-paradoxical-effect-methylphenidate-treatment-patient-severe-traumatic.htm
Is it acceptable for people to take methylphenidate to enhance performance? No.
16 Jun 2009
rec_pub_19541706-is-acceptable-people-methylphenidate-enhance-performance-no.htm
Is it acceptable for people to take methylphenidate to enhance performance? Yes.
16 Jun 2009
rec_pub_19541705-is-acceptable-people-methylphenidate-enhance-performance-yes.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]